Standards, Options and Recommendations for the use of appetite stimulants in oncology (2000)
暂无分享,去创建一个
P. Bachmann | R. Benamouzig | J. Desport | S. Schneider | J. Melchior | G. Nitenberg | V. Colomb | P. Senesse | B. Raynard | M. Blanc-Vincent | D. Kere | G. Gory-Delabaere | J. Béal
[1] J. Dickerson,et al. Malignant disease: nutritional implications of disease and treatment , 2004, Cancer and Metastasis Reviews.
[2] F. Bozzetti. Nutritional Support in Patients with Cancer , 2015 .
[3] J. Renaud-salis,et al. SOR: project methodology , 2001, British Journal of Cancer.
[4] P. Bachmann,et al. Standards, Options and Recommendations (SOR) for the use of appetite stimulants in oncology , 2000 .
[5] P. Bachmann,et al. [Standards, Options and Recommendations (SOR) for the use of appetite stimulants in oncology. Work group. Federation of the French Cancer Centres (FNCLCC)]. , 2000, Bulletin du cancer.
[6] E. Zecca,et al. Megestrol acetate for anorexia in patients with far-advanced cancer: a double-blind controlled clinical trial. , 1998, European journal of cancer.
[7] M. Puccio,et al. The cancer cachexia syndrome. , 1997, Seminars in oncology.
[8] D. Walsh,et al. The symptoms of advanced cancer. , 1995, Seminars in oncology.
[9] F. Bozzetti,et al. Anorexia in cancer patients: prevalence and impact on the nutritional status. , 1989, Clinical nutrition.
[10] J. Faintuch. [Nutritional support in patients with cancer]. , 1981, Revista do Hospital das Clinicas.